Melinta Therapeutics Enters Agreement To Acquire Infectious Disease Business From The Medicines Company
Nov 29 (Reuters) - Melinta Therapeutics, Inc.
Latest Developments forMelinta Therapeutics, Inc.
- Medicines Company Announces Definitive Agreement To Sell Its Infectious Disease Business Unit To Melinta Therapeutics
- Melinta Therapeutics, Cempra name Daniel Wechsler as CEO of combined company
- Cempra appoints David Zaccardelli as acting CEO
- Cempra says current cash, equivalents sufficient to fund ongoing operations through 2017